A nurse is caring for a client who has a kidney transplant and is receiving cyclosporine (Sandimmune), a calcineurin inhibitor. What is the primary mechanism of action of cyclosporine in this condition?
A It inhibits the synthesis of inflammatory mediators and suppresses the activation and proliferation of immune cells.
B It blocks the activation of T cells by inhibiting the enzyme calcineurin, which is required for the transcription of interleukin-2.
C It interferes with the synthesis of nucleic acids, which are essential for the replication and function of immune cells.
D It binds to specific antigens or receptors on the surface of immune cells and either neutralizes them or induces their destruction.
The Correct Answer and Explanation is:
The primary mechanism of action of cyclosporine (Sandimmune) in the context of kidney transplantation is:
B. It blocks the activation of T cells by inhibiting the enzyme calcineurin, which is required for the transcription of interleukin-2.
Explanation:
Cyclosporine is an immunosuppressant medication that plays a crucial role in preventing organ rejection after kidney transplantation. Its main action involves the inhibition of T-cell activation, which is critical for the immune response that can lead to transplant rejection.
Mechanism of Action:
- Inhibition of Calcineurin: Cyclosporine specifically inhibits the enzyme calcineurin. Calcineurin is a calcium-dependent serine/threonine phosphatase enzyme that is essential for the activation of T-cells. Under normal circumstances, calcineurin dephosphorylates nuclear factor of activated T-cells (NFAT), which then translocates to the nucleus and initiates the transcription of interleukin-2 (IL-2) and other cytokines.
- Impact on Interleukin-2 (IL-2): Interleukin-2 is a key cytokine involved in the proliferation and activation of T-cells. By inhibiting calcineurin, cyclosporine prevents the activation of NFAT, which in turn inhibits the transcription of IL-2. This reduction in IL-2 levels decreases the proliferation and activation of T-cells, leading to a suppressed immune response.
- Clinical Effect: By suppressing the activation of T-cells, cyclosporine reduces the likelihood of acute rejection episodes following kidney transplantation. This immunosuppressive action is vital because the transplanted kidney is recognized as a foreign object by the recipient’s immune system. Without adequate suppression of the immune response, the body would attack the transplanted organ.
Alternative Options:
- Option A: Involves inhibition of inflammatory mediators, which is not the primary action of cyclosporine. This option is more characteristic of other immunosuppressants or anti-inflammatory drugs.
- Option C: Refers to inhibition of nucleic acid synthesis, which is not the primary mechanism of cyclosporine. This mechanism is more associated with other drugs like antimetabolites (e.g., azathioprine).
- Option D: Describes the action of drugs that bind to specific antigens or receptors, which is not applicable to cyclosporine’s mechanism of action.
In summary, cyclosporine’s primary action in kidney transplantation is the inhibition of calcineurin, leading to reduced activation of T-cells and subsequently less production of IL-2, which helps in preventing transplant rejection.